- Home
- ARTW vs APM Comparison
ARTW vs APM Comparison
Compare ARTW & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARTW | APM |
|---|---|---|
| Founded | 1956 | 2010 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 8.0M |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ARTW | APM |
|---|---|---|
| Price | $2.32 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 39.8K | 21.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $22,975,408.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.60 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $0.65 |
| 52 Week High | $4.69 | $4.47 |
Technical Indicators
Market Signals| Indicator | ARTW | APM |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 44.39 |
| Support Level | $2.21 | $0.74 |
| Resistance Level | $2.49 | $1.11 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 19.72 | 42.99 |
Price Performance
Historical ComparisonAbout ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.